Literature DB >> 22025264

Tumor microenvironment composition in pediatric classical Hodgkin lymphoma is modulated by age and Epstein-Barr virus infection.

Mário Henrique M Barros1, Gabriela Vera-Lozada, Fernando A Soares, Gerald Niedobitek, Rocio Hassan.   

Abstract

Classical Hodgkin lymphoma (cHL) is characterized by a small number of neoplastic cells in a background of reactive cells. Children and adults differ in constitution and functionality of the immune system and it is possible that there may be age-related differences in tumor microenvironment composition in cHL. One hundred children with pediatric cHL were studied. Tumor-infiltrating lymphocytes were analyzed by immunohistochemistry (IHC) and image analysis. Epstein-Barr virus (EBV) status was determined by EBER-specific in situ hybridization and IHC. Results were analyzed in the context of age-group, histological characteristics and clinical follow-up. EBV-status was not associated with age-group. Children<10 years and EBV+ cases were characterized by a more intense T cell infiltrate, exhibiting a cytotoxic/Th1 profile, characterized by higher numbers of CD3+, CD8+, TIA1+ and TBET+ lymphocytes. Extranodal disease (p=0.016) and high number of GranzymeB+ lymphocytes (p=0.04) were independently associated with reduced progression-free survival (PFS). Yet, in EBV+ cases, improved outcome was observed in cases with low numbers of FOXP3+ lymphocytes (p=0.046), FOXP3/CD8 ratio<1 (p=0.021) and TBET/CMAF ratio<1 (p=0.017). By contrast, in EBV- cases, poor survival was observed in cases with extranodal disease (p=0.028), MC subtype (p=0.009) and high numbers of TIA1+ (p=0.044) and GranzymeB+ (p=0.04) lymphocytes. The results suggest that in EBV+ cHL an effective immune response directed against viral or tumor antigens may be triggered in the tumor microenvironment and that physiological and age-related changes of the immune system may also modulate the tumor microenvironment in pediatric cHL.
Copyright © 2011 UICC.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22025264     DOI: 10.1002/ijc.27314

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  25 in total

1.  Pediatric Hodgkin Lymphoma: on the road to a 'radiotherapy-free' cure rate?-Commentary on a report on final results of the Multinational Trial GPOH-HD95.

Authors:  Gaetano Corazzelli
Journal:  Transl Pediatr       Date:  2013-07

2.  The interplay between local immune response and Epstein-Barr virus-infected tonsillar cells could lead to viral infection control.

Authors:  Aldana G Vistarop; Melina Cohen; Fuad Huaman; Lucia Irazu; Marcelo Rodriguez; Elena De Matteo; María Victoria Preciado; Paola A Chabay
Journal:  Med Microbiol Immunol       Date:  2018-07-25       Impact factor: 3.402

3.  Epstein-Barr virus DNA in serum as an early prognostic marker in children and adolescents with Hodgkin lymphoma.

Authors:  Jennifer J G Welch; Cindy L Schwartz; Meghan Higman; Lu Chen; Allen Buxton; Jennifer A Kanakry; Samir B Kahwash; Robert E Hutchison; Debra L Friedman; Richard F Ambinder
Journal:  Blood Adv       Date:  2017-04-24

4.  Defining characteristics of classical Hodgkin lymphoma microenvironment T-helper cells.

Authors:  Paul Greaves; Andrew Clear; Andrew Owen; Sameena Iqbal; Abigail Lee; Janet Matthews; Andrew Wilson; Maria Calaminici; John G Gribben
Journal:  Blood       Date:  2013-09-04       Impact factor: 22.113

5.  Epstein-Barr virus recruits PDL1-positive cells at the microenvironment in pediatric Hodgkin lymphoma.

Authors:  O Jimenez; S Colli; M Garcia Lombardi; M V Preciado; E De Matteo; P Chabay
Journal:  Cancer Immunol Immunother       Date:  2020-11-12       Impact factor: 6.968

6.  Prognostic Analysis of Absolute Lymphocyte and Monocyte Counts after Autologous Stem Cell Transplantation in Children, Adolescents, and Young Adults with Refractory or Relapsed Hodgkin Lymphoma.

Authors:  Jorge Galvez-Silva; Ossama M Maher; Minjeong Park; Diane Liu; Fiorela Hernandez; Priti Tewari; Yago Nieto
Journal:  Biol Blood Marrow Transplant       Date:  2017-04-20       Impact factor: 5.742

7.  Flow cytometry for assessment of the tumor microenvironment in pediatric Hodgkin lymphoma.

Authors:  Meret Henry; Steven Buck; Süreyya Savaşan
Journal:  Pediatr Blood Cancer       Date:  2018-07-15       Impact factor: 3.167

8.  Genotyping circulating tumor DNA of pediatric Hodgkin lymphoma.

Authors:  Ann-Kathrin Desch; Kristin Hartung; Ante Botzen; Alexander Brobeil; Mathias Rummel; Lars Kurch; Thomas Georgi; Theresa Jox; Stefan Bielack; Stefan Burdach; Carl Friedrich Classen; Alexander Claviez; Klaus-Michael Debatin; Martin Ebinger; Angelika Eggert; Jörg Faber; Christian Flotho; Michael Frühwald; Norbert Graf; Norbert Jorch; Udo Kontny; Christof Kramm; Andreas Kulozik; Joachim Kühr; Karl-Walter Sykora; Markus Metzler; Hermann L Müller; Michaela Nathrath; Thomas Nüßlein; Michael Paulussen; Arnulf Pekrun; Dirk Reinhardt; Harald Reinhard; Claudia Rössig; Axel Sauerbrey; Paul-Gerhardt Schlegel; Dominik T Schneider; Wolfram Scheurlen; Lothar Schweigerer; Thorsten Simon; Meinolf Suttorp; Peter Vorwerk; Roland Schmitz; Regine Kluge; Christine Mauz-Körholz; Dieter Körholz; Stefan Gattenlöhner; Andreas Bräuninger
Journal:  Leukemia       Date:  2019-08-20       Impact factor: 11.528

Review 9.  Thyroid nodule as a first manifestation of Hodgkin lymphoma-report of two cases and literature review.

Authors:  Ewelina Szczepanek-Parulska; Malgorzata Szkudlarek; Przemyslaw Majewski; Jan Breborowicz; Marek Ruchala
Journal:  Diagn Pathol       Date:  2013-07-15       Impact factor: 2.644

10.  Relationship of Epstein-Barr virus and interleukin 10 promoter polymorphisms with the risk and clinical outcome of childhood Burkitt lymphoma.

Authors:  Carolina Minnicelli; Mário H M Barros; Claudete E Klumb; Sérgio O Romano; Ilana R Zalcberg; Rocio Hassan
Journal:  PLoS One       Date:  2012-09-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.